Top

Journal of Neuroinflammation

Published in:

Open Access 01-12-2012 | Research

Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia

Authors: Famakin Bolanle, Mou Yongshan, Spatz Maria, Lawal Modinat, John Hallenbeck

Published in: Journal of Neuroinflammation | Issue 1/2012

Abstract

Background

Deletion of some Toll-like receptors (TLRs) affords protection against cerebral ischemia, but disruption of their known major downstream adaptors does not. To determine whether compensation in the production of downstream effectors by one pathway when the other is disrupted can explain these findings, we examined cytokine/chemokine expression and inflammatory infiltrates in wild-type (WT), MyD88^−/− and TRIF-mutant mice following permanent middle cerebral artery occlusion (pMCAO).

Methods

Cytokine/chemokine expression was measured with a 25-plex bead array in the serum and brains of all three groups of mice at baseline (no surgery/naïve) and at 3 hours and 24 hours following pMCAO. Brain inflammatory and neutrophil infiltrates were examined 24 hours following pMCAO.

Results

IL-6, keratinocyte chemoattractant (KC), granulocyte colony-stimulating factor (G-CSF) and IL-10 were significantly decreased in MyD88^−/− mice compared to WT mice following pMCAO. Significantly, decreased levels of the neutrophil chemoattractants KC and G-CSF corresponded with a trend toward fewer neutrophils in the brains of MyD88^−/− mice. IP-10 was significantly decreased when either pathway was disrupted. MIP-1α was significantly decreased in TRIF-mutant mice, consistent with TRIF-dependent production. MyD88^−/− mice showed elevations of a number of Th2 cytokines, such as IL-13, at baseline, which became significantly decreased following pMCAO.

Conclusions

Both MyD88 and TRIF mediate pathway-specific cytokine production following focal cerebral ischemia. Our results also suggest a compensatory Th2-type skew at baseline in MyD88^−/− mice and a paradoxical switch to a Th1 phenotype following focal cerebral ischemia. The MyD88 pathway directs the expression of neutrophil chemoattractants following cerebral ischemia.

Takeda K, Akira S: TLR signaling pathways. Semin Immunol 2004, 16:3–9.CrossRefPubMed

Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM: Toll-like receptors in ischemia-reperfusion injury. Shock 2009, 32:4–16.CrossRefPubMed

Wang YC, Lin S, Yang QW: Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation 2011, 8:134.CrossRefPubMedPubMedCentral

Matzinger P: The danger model: a renewed sense of self. Science 2002, 296:301–305.CrossRefPubMed

Medzhitov R: Toll-like receptors and innate immunity. Nat Rev 2001, 1:135–145. Immunology

Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I: Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599–1608.CrossRefPubMed

Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H, Nietfeld W, Trendelenburg G: TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 2007, 359:574–579.CrossRef

Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP: Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007, 104:13798–13803.CrossRefPubMedPubMedCentral

Famakin BM, Mou Y, Ruetzler CA, Bembry J, Maric D, Hallenbeck JM: Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia. Brain Res 2011, 1388:148–156.CrossRefPubMed

10.

Tsung A, Stang MT, Ikeda A, Critchlow ND, Izuishi K, Nakao A, Chan MH, Jeyabalan G, Yim JH, Geller DA: The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1261-G1268.CrossRefPubMed

11.

Hua F, Ha T, Ma J, Gao X, Kelley J, Williams DL, Browder IW, Kao RL, Li C: Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts. Biochem Biophys Res Commun 2005, 338:1118–1125.CrossRefPubMed

12.

Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 2007, 178:6252–6258.CrossRefPubMed

13.

Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C: Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002, 22:308–317.CrossRefPubMed

14.

Brown HC, Kristenssen T, Rothaul A, Perry VH: The influence of plasma proteins on the distribution of leucocytes within the brain parenchyma in a murine model of stroke. Neuropathol Appl Neurobiol 1998, 24:177–186.CrossRefPubMed

15.

Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143–150.CrossRefPubMed

16.

Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B: Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003, 424:743–748.CrossRefPubMed

17.

Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, Kawase T, Mihara M, Ohsugi Y, Abe K, Okano H: Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 2005, 94:459–468.CrossRefPubMed

18.

Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F: Time course of IL-6 expression in experimental CNS ischemia. Neurol Res 1999, 21:287–292.CrossRefPubMed

19.

Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F: Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000, 31:1715–1720.CrossRefPubMed

20.

Bozic CR, Kolakowski LF, Gerard NP, Garcia-Rodriguez C, von Uexkull-Guldenband C, Conklyn MJ, Breslow R, Showell HJ, Gerard C: Expression and biologic characterization of the murine chemokine KC. J Immunol 1995, 154:6048–6057.PubMed

21.

De Filippo K, Henderson RB, Laschinger M, Hogg N: Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. J Immunol 2008, 180:4308–4315.CrossRefPubMed

22.

Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S: Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol 2009, 183:6629–6638.CrossRefPubMedPubMedCentral

23.

Ventura GMD, Balloy V, Ramphal R, Khun H, Huerre M, Ryffel B, Plotkowski MCM, Chignard M, Si-Tahar M: Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia. J Immunol 2009, 183:670–676.CrossRefPubMed

24.

Hasselblatt M, Jeibmann A, Riesmeier B, Maintz D, Schabitz WR: Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol 2007, 113:45–51.CrossRefPubMed

25.

Popa-Wagner A, Stocker K, Balseanu AT, Rogalewski A, Diederich K, Minnerup J, Margaritescu C, Schabitz WR: Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke 2010, 41:1027–1031.CrossRefPubMed

26.

Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, Nikol S, Kirsch F, Schneider A, Schabitz WR: Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol 2009, 217:328–335.CrossRefPubMed

27.

Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH: Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res 2009, 31:167–172.CrossRefPubMed

28.

Solaroglu I, Tsubokawa T, Cahill J, Zhang JH: Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965–974.CrossRefPubMedPubMedCentral

29.

Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM: Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry 2006, 77:1279–1281.CrossRefPubMedPubMedCentral

30.

Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD: Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006, 26:654–665.CrossRefPubMed

31.

Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947–950.CrossRefPubMed

32.

von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Aróstegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yagüe J, Antón J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Maródi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova JL: Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691–696.CrossRefPubMedPubMedCentral

33.

Nance SC, Yi AK, Re FC, Fitzpatrick EA: MyD88 is necessary for neutrophil recruitment in hypersensitivity pneumonitis. J Leukoc Biol 2008, 83:1207–1217.CrossRefPubMedPubMedCentral

Title: Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia
Authors: Famakin Bolanle
Mou Yongshan
Spatz Maria
Lawal Modinat
John Hallenbeck
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2012
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/1742-2094-9-174

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

Liposomal clodronate selectively eliminates microglia from primary astrocyte cultures

Tumor necrosis factor-α-mediated threonine 435 phosphorylation of p65 nuclear factor-κB subunit in endothelial cells induces vasogenic edema and neutrophil infiltration in the rat piriform cortex following status epilepticus

Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation

Metabotropic glutamate receptor 5 contributes to inflammatory tongue pain via extracellular signal-regulated kinase signaling in the trigeminal spinal subnucleus caudalis and upper cervical spinal cord

Histamine modulates microglia function